Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy
Nanoscale · 2024
DOI: 10.1039/d3nr06131k ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2024. Verfasst von Puja Sandbhor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for NanoBioTechnology, Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA. p00jasandb…. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 234 Literaturangaben.
Abstract (Originalsprache)
Graphical representation of recent advancements in combinatorial anticancer treatment modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute for NanoBioTechnology, Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA. p00jasandbhor@gmail.com.
- Radiobiology, Department of Radiation Oncology & Homi Bhabha National Institute, Mumbai, 400012, India.
Zitieren
APA
Sandbhor, P., Palkar, P., Bhat, S., John, G., & Goda, J. S. (2024). Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. Nanoscale. https://doi.org/10.1039/d3nr06131k
Vancouver
Sandbhor P, Palkar P, Bhat S, John G, Goda JS. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. Nanoscale. 2024. doi:10.1039/d3nr06131k
BibTeX
@article{Sandbhor2024,
author = {Sandbhor, Puja and Palkar, Pranoti and Bhat, Sakshi and John, Geofrey and Goda, Jayant S},
title = {Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy},
journal = {Nanoscale},
year = {2024},
doi = {10.1039/d3nr06131k}
}
EUVIMED